Business Context and Reporting Period
This Form 8-K Current Report was filed by AngioDynamics, Inc. on November 9, 2015, covering events occurring on November 3, 2015. The filing addresses significant changes in executive leadership, specifically the departure of the Chief Financial Officer and the appointment of an interim successor.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel changes and associated compensation arrangements.
Material Changes
- Resignation of CFO: Mark Frost, Executive Vice President and Chief Financial Officer, resigned effective November 3, 2015, to join Analogic Corporation. He will remain available to the company through November 20, 2015.
- Appointment of Interim CFO: Michael Trimarchi, Vice President and Global Controller, was appointed Interim Chief Financial Officer effective November 9, 2015.
- Reason for Departure: The filing explicitly states that Mr. Frost is not resigning due to any disagreement regarding the Company's operations, policies, or practices.
Management Commentary, Risks, and Unusual Items
Compensatory Arrangements: In connection with his appointment as Interim CFO, the Compensation Committee approved an $80,000 cash retention bonus for Mr. Trimarchi. This bonus is payable subject to his continued employment through May 6, 2016, or if he is terminated without cause or resigns for good reason prior to that date.
Severance Benefits: Mr. Trimarchi is eligible for severance benefits equal to twelve months of base pay, commensurate with other executive officers.
Search for Successor: The Company has initiated a search for a permanent successor to the CFO position.
Investor Verification Checklist
- Verify the transition timeline and handover status between Mr. Frost and Mr. Trimarchi.
- Monitor the progress of the search for a permanent Chief Financial Officer.
- Review the attached press release (Exhibit 99.1) for additional public commentary on the leadership change.
- Confirm that no undisclosed disagreements exist regarding the company's financial reporting or operations, as stated in the filing.